JamesCorneliusJames Cornelius, a board member who was previously chief executive at device maker Guidant and chief financial officer at drugmaker Eli Lilly, will take over as interim CEO.
James Cornelius , a board member who was previously chief executive at device maker Guidant and chief financial officer at drugmaker Eli Lilly (nyse: LLY - news - people ), will take over as interim CEO.